Live Breaking News & Updates on ரீடிஂக் பள்ளி ஆஃப் மருந்தகம்
Stay updated with breaking news from ரீடிஂக் பள்ளி ஆஃப் மருந்தகம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Is it time to ditch the daily Covid stats? dailymail.co.uk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailymail.co.uk Daily Mail and Mail on Sunday newspapers.
Saturday April 10, 2021, 9:29 AM Under the plans, post-arrival tests must be the polymerase chain reaction (PCR) type which are thought to be more accurate, but are more expensive. The PCR tests differ from Lateral Flow Tests (LFT) which are widely being used in schools around the country. So what are the differences between them? PCR tests require lab analysis meaning they take longer to process. Credit: PA What is the difference between how the tests work? Polymerase chain reaction (PCR) tests are often seen as the gold standard test for identifying clinical cases of infection because it requires laboratory analysis. The PCR is a diagnostic test that detects the virus’s RNA (genetic material) in a sample taken from a nose and throat swab. ....
Share Millions around the world who face the risk of deadly and disabling venomous snakebites will benefit from experts helping the WHO to tackle the neglected issue. The World Health Organisation has drawn together a roster of leading experts from around the world, including leading UK snakebite scientist Dr Sakthi Vaiyapuri from the University of Reading. Dr Vaiyapuri will join other snakebite scientists to help enact the WHO’s strategy for stopping deaths from snakebites around the world. Dr Vaiyapuri’s research is focused on new biomedical technology and treatments for venomous snakebites, and led a public health campaign in 2018 and 2019 in Southern India to educate rural communities about treating snakebites. The low-cost campaign reached more than 3 million residents and led to improved health outcomes for snakebite victims in the region. ....
The interim trial results of Sputnik V, the coronavirus vaccine developed by Russia, are in, and results are showing 91.6 percent effectiveness in preventing symptomatic cases, as reported by CNN. There were no severe adverse events that appeared to be associated with the vaccine and the only side effects reported being mild, consisting of flu-like symptoms, pain at the injection site and low energy. Following the phase three trial of the vaccine, interim data suggests that two doses of Sputnik V reach a comparable level of effectiveness to those developed by Pfizer and Moderna. It also appears to provide a similar level of protection to those over 60. The data was gathered through a study involving almost 20,000 participants, with three-quarters receiving the vaccine and one-quarter receiving a placebo. ....